For example, binding to cysteine residues in the oncoprotein PML-RARα underlies the anticancer activity of arsenic trioxide in individuals with acute promyelocytic leukemia (APL) (Lallemand-Breitenbach et al., 2008; Zhang et al., 2010). The gene discussed is RARA; the disease is acute promyelocytic leukemia.